Cargando…
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
BACKGROUND: A5350, a phase II, randomized, double-blind study, evaluated the safety and tolerability of the probiotic Visbiome Extra Strength (ES) over 24 weeks and measured effects on inflammation and intestinal barrier function. METHODS: The primary outcome was change in soluble CD14 (sCD14) level...
Autores principales: | Presti, Rachel M, Yeh, Eunice, Williams, Brett, Landay, Alan, Jacobson, Jeffrey M, Wilson, Cara, Fichtenbaum, Carl J, Utay, Netanya S, Dube, Michael P, Klingman, Karin L, Estes, Jacob D, Flynn, Jacob K, Loftin, Amanda, Brenchley, Jason M, Andrade, Adriana, Kitch, Douglas W, Overton, Edgar T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651169/ https://www.ncbi.nlm.nih.gov/pubmed/34888397 http://dx.doi.org/10.1093/ofid/ofab550 |
Ejemplares similares
-
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy
por: O’Brien, Meagan P., et al.
Publicado: (2017) -
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIV
por: Dorazio, Dominic, et al.
Publicado: (2019) -
Interferons and HIV Infection: The Good, the Bad, and the Ugly
por: Utay, Netanya S., et al.
Publicado: (2016) -
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
por: Stevenson, Heather L., et al.
Publicado: (2016) -
Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART
por: Utay, Netanya S., et al.
Publicado: (2019)